CRP and FCGR2A genes have an epistatic effect on carotid artery intima-media thickness: The Cardiovascular Risk in Young Finns Study

International Journal of Immunogenetics

Volumn 36, Issue 1, 2009, Pages 39-45

  Pessi, T ^a   Eklund, C ^a   Huhtala, H ^a   Raitakari, O T ^b   Juonala, M ^c   Kahonen M ^d   Viikari, J S A ^b   Lehtimaki T ^d   Hurme, M ^a,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FC RECEPTOR IIA;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHILD; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; ALLELES; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPISTASIS, GENETIC; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, IGG; SEX FACTORS; TUNICA INTIMA; YOUNG ADULT;

EID: 58849106384     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2008.00818.x     Document Type: Article

References (51)

1. Abraham, J., Campbell, C.Y., Cheema, A., Gluckman, T.J., Blumenthal, R.S. Danyi, P. (2007) C-reactive protein in cardiovascular risk assessment: a review of the evidence. Journal of the Cardiometabolic Syndrome, 2, 119.
2. Akerblom, H.K., Viikari, J., Uhari, M., Rasanen, L., Byckling, T., Louhivuori, K. et al 1985) Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatrica Scandinavica. Supplement, 318, 49.
3. Bharadwaj, D., Stein, M.P., Volzer, M., Mold, C. Du Clos, T.W. (1999) The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. The Journal of Experimental Medicine, 190, 585.
4. Bodman-Smith, K.B., Melendez, A.J., Campbell, I., Harrison, P.T., Allen, J.M. Raynes, J.G. (2002) C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI). Immunology, 107, 252.
5. Burke, A.P., Tracy, R.P., Kolodgie, F., Malcom, G.T., Zieske, A., Kutys, R. et al 2002) Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation, 105, 2019.
6. Carlson, C.S., Aldred, S.F., Lee, P.K., Tracy, R.P., Schwartz, S.M., Rieder, M. et al 2005) Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. American Journal of Human Genetics, 77, 64.
7. Casas, J.P., Shah, T., Cooper, J., Hawe, E., McMahon, A.D., Gaffney, D. et al 2006) Insight into the nature of the CRP-coronary event association using Mendelian randomization. International Journal of Epidemiology, 35, 922.
8. Chen, J., Zhao, J., Huang, J., Su, S., Qiang, B. Gu, D. (2005) -717A > G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study. Journal of Molecular Medicine, 83, 72.
9. Cushman, M., Arnold, A.M., Psaty, B.M., Manolio, T.A., Kuller, L.H., Burke, G.L. et al 2005) C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation, 112, 25.
10. Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P. et al 2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal, 321, 199.
11. Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A. et al 2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 350, 1387.
12. Devaraj, S., Xu, D.Y. Jialal, I. (2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 107, 398.
13. Devaraj, S., Du Clos, T.W. Jialal, I. (2005) Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arteriosclerosis Thrombosis and Vascular Biology, 25, 1359.
14. Devaraj, S., Venugopal, S. Jialal, I. (2006) Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis, 184, 48.
15. Eklund, C., Kivimäki, M., Islam, M.S., Juonala, M., Kähönen, M., Marniemi, J. et al 2008) C-reactive protein genetics is associated with carotid artery compliance in men in the Cardiovascular Risk in Young Finns Study. Atherosclerosis, 196, 841.
16. Fu, T. Borensztajn, J. (2002) Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions. The Biochemical Journal, 366, 195.
17. Gavasso, S., Nygard, O., Pedersen, E.R., Aarseth, J.H., Bleie, O., Myhr, K.M. et al 2005) Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis, 180, 277.
18. Janeway, C.A. Jr Medzhitov, R. (2002) Innate immune recognition. Annual Review of Immunology, 20, 197.
19. Ji, S.R., Wu, Y., Zhu, L., Potempa, L.A., Sheng, F.L., Lu, W. et al 2007) Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP (m). The FASEB Journal, 21, 284.
20. Juonala, M., Järvisalo, M.J., Mäki-Torkko, N., Kähönen, M., Viikari, J.S. Raitakari, O.T. (2005) Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation, 112, 1486.
21. Juonala, M., Viikari, J.S., Laitinen, T., Marniemi, J., Helenius, H., Rönnemaa, T. et al 2004) Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Circulation, 110, 2918.
22. Kardys, I., de Maat, M.P., Uitterlinden, A.G., Hofman, A. Witteman, J.C. (2006) C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. European Heart Journal, 27, 1331.
23. Kathiresan, S., Larson, M.G., Vasan, R.S., Guo, C.Y., Gona, P., Keaney, J.F. Jr et al 2006) Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation, 113, 1415.
24. Katrinchak, C. Fritz, K. (2007) Clinical implications of C-reactive protein as a predictor of vascular risk. Journal of the American Academy of Nurse Practitioners, 19, 335.
25. Kivimäki, M., Lawlor, D.A., Eklund, C., Smith, G.D., Hurme, M., Lehtimäki, T. et al 2007) Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study. Arteriosclerosis Thrombosis and Vascular Biology, 27, 978.
26. Kivimäki, M., Lawlor, D.A., Juonala, M., Smith, G.D., Elovainio, M., Keltikangas-Jarvinen, L. et al 2005) Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Arteriosclerosis Thrombosis and Vascular Biology, 25, 2197.
27. Lange, L.A., Carlson, C.S., Hindorff, L.A., Lange, E.M., Walston, J., Durda, J.P. et al 2006) Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. Jama, 296, 2703.
28. van der Meer, I.M., Witteman, J.C., Hofman, A., Kluft, C. de Maat, M.P. (2004) Genetic variation in Fcgamma receptor IIa protects against advanced peripheral atherosclerosis. The Rotterdam Study. Thrombosis and Haemostasis, 92, 1273.
29. Miller, D.T., Zee, R.Y., Suk Danik, J., Kozlowski, P., Chasman, D.I., Lazarus, R. et al 2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Annals of Human Genetics, 69, 623.
30. Moore, J.H. (2005) A global view of epistasis. Nature Genetics, 37, 13.
31. Pasceri, V., Cheng, J.S., Willerson, J.T. Yeh, E.T. (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 103, 2531.
32. Pasceri, V., Willerson, J.T. Yeh, E.T. (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102, 2165.
33. Raitakari, O.T. (1999) Imaging of subclinical atherosclerosis in children and young adults. Annals of Medicine, 31 (Suppl. 1 33.
34. Raitakari, O.T., Juonala, M., Kähönen, M., Taittonen, L., Laitinen, T., Mäki-Torkko, N. et al 2003) Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Jama, 290, 2277.
35. Rao, M., Jaber, B.L. Balakrishnan, V.S. (2006) Inflammatory biomarkers and cardiovascular risk: association or cause and effect? Seminars in Dialysis, 19, 129.
36. Ridker, P.M., Buring, J.E., Shih, J., Matias, M. Hennekens, C.H. (1998a) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 98, 731.
37. Ridker, P.M., Glynn, R.J. Hennekens, C.H. (1998b) C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation, 97, 2007.
38. Rothman, K.J. (1990) No adjustments are needed for multiple comparisons. Epidemiology, 1, 43.
39. Ryu, J., Lee, C.W., Shin, J.A., Park, C.S., Kim, J.J., Park, S.J. et al 2007) FcgammaRIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4. Cardiovascular Research, 75, 555.
40. Stein, M.P., Edberg, J.C., Kimberly, R.P., Mangan, E.K., Bharadwaj, D., Mold, C. et al 2000) C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. Journal of Clinical Investigation, 105, 369.
41. Taskinen, S., Kovanen, P.T., Jarva, H., Meri, S. Pentikainen, M.O. (2002) Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein. Biochemical Journal, 367, 403.
42. Taskinen, S., Hyvönen, M., Kovanen, P.T., Meri, S. Pentikainen, M.O. (2005) C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles. Biochemical and Biophysical Research Communications, 329, 1208.
43. Torzewski, M., Rist, C., Mortensen, R.F., Zwaka, T.P., Bienek, M., Waltenberger, J. et al 2000) C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arteriosclerosis Thrombosis and Vascular Biology, 20, 2094.
44. Venugopal, S.K., Devaraj, S. Jialal, I. (2005) Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Current Opinion in Nephrology and Hypertension, 14, 33.
45. Venugopal, S.K., Devaraj, S., Yuhanna, I., Shaul, P. Jialal, I. (2002) Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation, 106, 1439.
46. Verma, S., Li, S.H., Badiwala, M.V., Weisel, R.D., Fedak, P.W., Li, R.K. et al 2002) Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 105, 1890.
47. Wang, C.H., Li, S.H., Weisel, R.D., Fedak, P.W., Dumont, A.S., Szmitko, P. et al 2003) C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation, 107, 1783.
48. Wilson, A.M., Swan, J.D., Ding, H., Zhang, Y., Whitbourn, R.J., Gurry, J. et al 2007) Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy. Atherosclerosis, 191, 175.
49. Wolford, J.K., Gruber, J.D., Ossowski, V.M., Vozarova, B., Antonio Tataranni, P., Bogardus, C. et al 2003) A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Molecular Genetics and Metabolism, 78, 136.
50. Yasojima, K., Schwab, C., McGeer, E.G. McGeer, P.L. (2001) Generation of C-reactive protein and complement components in atherosclerotic plaques. The American Journal of Pathology, 158, 1039.
51. Zee, R.Y. Ridker, P.M. (2002) Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis, 162, 217.